01618nam a2200421 i 4500001001300000003000600013005001700019006001900036007001500055008004100070040002700111042000800138043001200146074002300158086002800181088002000209099002800229110010000257245006200357246009700419264010300516300005200619337001300671338001500684500005200699500001700751500002300768500002500791504004100816650001400857650004100871650004200912610007200954776009501026856003801121949001801159999001901177ocn960809637OCoLC20170208053812.0m     o  d f      cr mn|||||||||161017s1995    dcua    ob   f000 0 eng c  aGPObengerdaepncGPO  apcc  an-us---  a0445-B-07 (online)0 aHE 1.75:OEI-05-94-00130  aOEI-05-94-00130  aHE 1.75:OEI-05-94-001301 aUnited States.bDepartment of Health and Human Services.bOffice of Inspector General,eauthor.10aCLIA's impact on the availability of laboratory services.3 aClinical Laboratory Improvement Amendments impact on the availability of laboratory services 1a[Washington, D.C.] :bDepartment of Health and Human Services, Office of Inspector General,c1995.  a1 online resource ([51] pages) :billustrations  2rdamedia  2rdacarrier  aTitle from title screen (viewed Oct. 14, 2016).  a"June 1995."  a"OEI-05-94-00130."  aCRDP Project record.  aIncludes bibliographical references. 0aMedicare. 0aMedical laboratorieszUnited States. 0aDiagnosis, LaboratoryzUnited States.10aUnited States.tClinical Laboratory Improvement Amendments of 1988.08iPrint version:tCLIA's impact on the availability of laboratory servicesw(OCoLC)76819189440uhttp://purl.fdlp.gov/GPO/gpo73471  aBEVbFed Docs  c257039d257039